Australia's largest stock trading and investment forum Australia's #1 stock forum

SRX

0.00%

17.5¢ sierra rutile holdings limited

Ann: SIRFLOX Awarded Oral Presentation at ASCO, page-26

First 26 Last

Share
Profile

Follow
wild-1

1,255 Posts.

12

11/05/15

22:32

Post #: 15258722
Share

Originally posted by plasticd ↑

Hi cafa

I am pretty sure LBA signifies a late submission of an abstract when preliminary data not available

From the website
The ASCO late-breaking data policy allows for the submission of late-breaking data only for randomized phase II and III trials for which no preliminary data are available at the time of the abstract submission deadline (February 3, 2015), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before April 1, 2015 (the deadline for the final, updated late-breaking data). During abstract submission, you will be required to provide the primary clinical endpoint for analysis, type of analysis, date of planned analysis, and planned statistical methods for analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline.

My understanding is this is not the case for this trial in that the data was available at the time of abstract submission. LBA allows for presenters to submit an abstract when all the data hasn't been analysed yet but will be by April 1st.

I could be wrong but I don't believe this the case for this trial so we should expect this abstract to be published in a few days.

D

Expand

Preliminary data regarding primary endpoint for SIRFLOX was available in March. I may be wrong, but I suspect that makes this considered late breaking

SRX Price at posting: $19.05 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 18 more messages in this thread...

First 26 Last

Add SRX (ASX) to my watchlist

Ann: SIRFLOX Awarded Oral Presentation at ASCO, page-26

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News